Kwon NY, Sung Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  Google Scholar 

Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L. Current challenges in cancer treatment. Clin Ther. 2016;38(7):1551–66.

Article  PubMed  Google Scholar 

Avci FG, Akbulut BS, Ozkirimli E. Membrane active peptides and their biophysical characterization. Biomolecules. 2018;8(3):77.

Article  PubMed Central  PubMed  Google Scholar 

Zhou J, Wan C, Cheng J, et al. Delivery strategies for melittin-based cancer therapy. ACS Appl Mater Interfaces. 2021;13(15):17158–73.

Article  CAS  PubMed  Google Scholar 

Kwon NY, Sung SH, Sung HK, Park JK. Anticancer activity of bee venom components against breast cancer. Toxins. 2022;14(7):460.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Zhou Y, Zhang S, Chen Z, et al. Targeted delivery of secretory promelittin via novel Poly(lactone-co-β-amino ester) nanoparticles for treatment of breast cancer brain metastases. Adv Sci. 2020;7(5):1901866.

Article  CAS  Google Scholar 

Zhou Y, Ye T, Ye C, et al. Secretions from hypochlorous acid-treated tumor cells delivered in a melittin hydrogel potentiate cancer immunotherapy. Bioact Mater. 2021;9:541–53.

PubMed Central  PubMed  Google Scholar 

Han E, Kim D, Cho Y, Lee S, Kim J, Kim H. Development of polymersomes co-delivering doxorubicin and melittin to overcome multidrug resistance. Molecules. 2023;28(3):1087.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Guo Y, Zhang X, Wang SZ, Feng HH, Wu SY, Wu FG. Metal-phenolic network-facilitated “foe-to-friend” conversion of melittin for cancer immunotherapy with boosted abscopal effect. Research. 2023;6:0052.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Mohammed ER, Elmasry GF. Development of newly synthesised quinazolinone-based CDK2 inhibitors with potent efficacy against melanoma. J Enzyme Inhib Med Chem. 2022;37(1):686–700.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Jirawatnotai S, Hu Y, Michowski W, et al. A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature. 2011;474(7350):230–4.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Mansour GH, El-Magd MA, Mahfouz DH, et al. Bee venom and its active component Melittin synergistically potentiate the anticancer effect of sorafenib against HepG2 cells. Bioorg Chem. 2021;116:105329.

Article  CAS  PubMed  Google Scholar 

Tipgomut C, Wongprommoon A, Takeo E, Ittiudomrak T, Puthong S, Chanchao C. Melittin induced G1 cell cycle arrest and apoptosis in chago-K1 human bronchogenic carcinoma cells and inhibited the differentiation of THP-1 cells into tumour- associated macrophages. Asian Pac J Cancer Prev. 2018;19(12):3427–34.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Sun M, Wu Y, Zhou Z, Liu S, Mao S, Li G. Co-delivery of EGCG and melittin with self-assembled fluoro-nanoparticles for enhanced cancer therapy. Aging. 2023;15(11):4875–88.

PubMed Central  PubMed  Google Scholar 

Fahmy UA, Badr-Eldin SM, Aldawsari HM, et al. Potentiality of raloxifene loaded melittin functionalized lipidic nanovesicles against pancreatic cancer cells. Drug Deliv. 2022;29(1):1863–77.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Shi P, Xie S, Yang J, et al. Pharmacological effects and mechanisms of bee venom and its main components: recent progress and perspective. Front Pharmacol. 2022;13:1001553.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Obeidat M, Al-Khraisat IF, Jaradat DMM, et al. Mellitin peptide quantification in seasonally collected crude bee venom and its anticancer effects on myelogenous K562 human leukaemia cell line. BMC Complement Med Ther. 2023;23(1):132.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Rady I, Siddiqui IA, Rady M, Mukhtar H. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett. 2017;402:16–31.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Moghaddam FD, Mortazavi P, Hamedi S, Nabiuni M, Roodbari NH. Apoptotic effects of melittin on 4T1 breast cancer cell line is associated with Up regulation of Mfn1 and Drp1 mRNA expression. Anticancer Agents Med Chem. 2020;20(7):790–9.

Article  CAS  PubMed  Google Scholar 

Yu CL, Lee HL, Yang SF, et al. Protodioscin induces mitochondrial apoptosis of human hepatocellular carcinoma cells through eliciting ER stress-mediated IP3R targeting Mfn1/Bak expression. J Hepatocell Carcinoma. 2022;9:327–41.

Article  PubMed Central  PubMed  Google Scholar 

Peña-Blanco A, García-Sáez AJ. Bax, Bak and beyond—mitochondrial performance in apoptosis. FEBS J. 2018;285(3):416–31.

Article  PubMed  Google Scholar 

Ceremuga M, Stela M, Janik E, et al. Melittin-A natural peptide from bee venom which induces apoptosis in human leukaemia cells. Biomolecules. 2020;10(2):247.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Yan R, Dai W, Wu R, Huang H, Shu M. Therapeutic targeting m6A-guided miR-146a-5p signaling contributes to the melittin-induced selective suppression of bladder cancer. Cancer Lett. 2022;534:215615.

Article  CAS  PubMed  Google Scholar 

Soliman C, Eastwood S, Truong VK, Ramsland PA, Elbourne A. The membrane effects of melittin on gastric and colorectal cancer. PLoS ONE. 2019;14(10):e0224028.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Moreno M, Giralt E. Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan. Toxins. 2015;7(4):1126–50.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Liu M, Wang H, Liu L, Wang B, Sun G. Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy. J Transl Med. 2016;14(1):155.

Article  PubMed Central  PubMed  Google Scholar 

Xu T, Cui T, Peng L, Kong S, Zou J, Tian X. The anti-hepatocellular carcinoma activity of Mel-P15 is mediated by natural killer cells. Oncol Lett. 2017;14(6):6901–6.

PubMed Central  PubMed  Google Scholar 

Rocha MM, Dariva I, Zornoff GC, et al. A new therapeutic approach for bone metastasis in colorectal cancer: intratumoral melittin. J Venom Anim Toxins Incl Trop Dis. 2022;28:e20210067.

CAS  PubMed Central  PubMed  Google Scholar 

Fomitcheva-Khartchenko A, Kashyap A, Geiger T, Kaigala GV. Space in cancer biology: its role and implications. Trends Cancer. 2022;8(12):1019–32.

Article  CAS  PubMed  Google Scholar 

Huh JE, Kang JW, Nam D, et al. Melittin suppresses VEGF-A-induced tumor growth by blocking VEGFR-2 and the COX-2-mediated MAPK signaling pathway. J Nat Prod. 2012;75(11):1922–9.

Article  CAS  PubMed  Google Scholar 

Shin JM, Jeong YJ, Cho HJ, et al. Melittin suppresses HIF-1α/VEGF expression through inhibition of ERK and mTOR/p70S6K pathway in human cervical carcinoma cells. PLoS ONE. 2013;8(7):e69380.

Article  CAS  PubMed Central  PubMed  Google Scholar 

El Bakary NM, Alsharkawy AZ, Shouaib ZA, Barakat EMS. Role of bee venom and melittin on restraining angiogenesis and metastasis in γ-irradiated solid ehrlich carcinoma-bearing mice. Integr Cancer Ther. 2020;19:1–13.

Article  Google Scholar 

Aufschnaiter A, Kohler V, Khalifa S, et al. Apitoxin and its components against cancer, neurodegeneration and rheumatoid arthritis: limitations and possibilities. Toxins. 2020;12(2):66.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Liu S, Yu M, He Y, et al. Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology. 2008;47(6):1964–73.

Article  CAS  PubMed  Google Scholar 

Salimian F, Nabiuni M, Salehghamari E. Melittin prevents metastasis of epidermal growth factor-induced MDA-MB-231 cells through the inhibition of the SDF-1α/CXCR4 signaling pathway. Cell J. 2022;24(2):85–90.

PubMed Central  PubMed  Google Scholar 

Chen M, Rong R, Xia X. Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases. J Neuroinflamm. 2022;19(1):183.

Article  CAS